TABLE 1.
Details of the GWAS included in this study.
| Phenotype | Sample size | SNP | Year | Population | GWAS ID |
|---|---|---|---|---|---|
| Statin medication | 377,277 | 2023 | European | FinnGen | |
| Parabacteroides | 7,738 | 5,564,061 | 2022 | European | ebi-a-GCST90027770 |
| Ruminococcaceae UCG-009 | 14,306 | 5,418,432 | 2021 | European | ebi-a-GCST90017057 |
| Coprococcus 1 | 14,306 | 5,649,452 | 2021 | European | ebi-a-GCST90016983 |
| Desulfovibrio | 7,738 | 4,925,569 | 2022 | European | ebi-a-GCST90027815 |
| Ruminococcaceae UCG-010 | 14,306 | 5,545,122 | 2021 | European | ebi-a-GCST90017058 |
| Veillonellaceae | 14,306 | 5,688,519 | 2021 | European | ebi-a-GCST90016956 |